As of Aug 25
| -0.92 / -1.59%|
The 5 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 70.00, with a high estimate of 89.00 and a low estimate of 46.00. The median estimate represents a +22.91% increase from the last price of 56.95.
The current consensus among 7 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.